Daewoong Co., Ltd. (KRX:003090)

Market Cap	993.64B
Revenue (ttm)	2.06T
Net Income (ttm)	77.51B
Shares Out	40.89M
EPS (ttm)	1,895.61
PE Ratio	12.82
Forward PE	6.41
Dividend	200.00 (0.82%)
Ex-Dividend Date	Dec 29, 2025

Volume	78,705
Average Volume	140,127
Open	24,250
Previous Close	24,300
Day's Range	23,850 - 24,400
52-Week Range	17,420 - 28,850
Beta	0.95
RSI	58.77
Earnings Date	Nov 14, 2025

About Daewoong

Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd. in 2002. Daewoong Co., Ltd. was founded in 1945 and is headquartered in Seongnam, South...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1945
• Employees: 379
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 003090

Financial Performance

In 2024, Daewoong's revenue was 1.94 trillion, an increase of 6.79% compared to the previous year's 1.81 trillion. Earnings were 57.89 billion, a decrease of -62.08%.